LT-Labsystems
LT-Labsystems' Oli-GO allows a fast and easy analysis and charaterization of your stem cells during cultivation, resulting in quantitative and valid data
- Stage Prototype Ready
- Industry Biotechnology
- Location Tulln an der Donau, Austria
- Currency EUR
- Founded July 2015
- Employees 0
- Incorporation Type Other
- Website lt-labsystems.com
Company Summary
LT-Labsystems develops an innovative tool for stem cell analysis. Compared to traditional analysis methods, the product Oli-GO offers customers an easy to handle assay kit, reducing not only cost and time needed for experiments, but results in quantitative cell-specific data during the cell-cultivation period. The technology comes with the opertunity to revolutionize stem cell research, paving the way for a better treatment of many diseases.
Team
-
Co-Founder & CEODipl. Ing. Manfred Taschner studied Biotechnology at BOKU Vienna, Griffith University (Brisbane, AUS) and Harvard Medical School (Boston, USA). He previously worked for AFFiRiS AG (Preclinical Development of Synthetic Vaccines & Optimization of Vaccine Formulations)
-
Co-Founder & CSOVolker Lorber MSc graduated in Human Biology/Tissue Engineering (Zurich, CH). During a PhD-program in Basel (Onkology/Tissue Engineering) he learned much about stem cells and the challenges of analyzing them. He previously worked for AGES/Pharmmed (Regulatory Affairs) and AFFiRiS AG (Preclinical Development Biacore/FACS)
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.